Legionnaires’ Disease Outbreak Reported at Wisconsin Hospital
One person died and at least 10 others developed symptoms of Legionnaires disease at UW Health University Hospital in Madison, Wisconsin. The Director of Infection Control there says the outbreak is related to a reduction in waterflow at the facility...
Cashmere Bouquet Lawsuit
The talc in Cashmere Bouquet powder and similar products has been repeatedly linked to an increased risk for ovarian cancer, mesothelioma, and other life-threatening health conditions. Our lawyers are representing victims and their families who have been diagnosed with cancer...
Clubman Pinaud Talc Lawsuit
Despite the name, Clubman Pinaud Talc products have not contained actual talc since the 1970s, when the company replaced the ingredient with cornstarch. However, if you used Clubman Pinaud Talc prior to that, you may have been exposed to the...
Shower Seat Recall Class Action
Our class action lawyers are filing lawsuits for people who were injured by Signature Hardware wall-mounted shower seats, which were recalled in Dec. 2018 after being linked to hundreds of complaints and nearly 2 dozen injuries.
Shower Seat Recall Lawsuit
A Kentucky-based firm is recalling its wall-mounted shower seats after it received nearly 200 complaints of the seats breaking during use, including dozens of reports of serious injuries.
NeuroBlate Class Action
The U.S. Food & Drug Administration (FDA) is warning about the potential for severe brain damage resulting from an allegedly defective component in the NeuroBlate laser delivery probe, which was recalled by Monteris Medical in March 2018.
NeuroBlate Lawsuit
The NeuroBlate System, a brain surgery probe that utilizes laser therapy to remove cancerous tumors, was recalled in March 2018 after being linked to multiple reports of brain damage -- including at least one which resulted in death -- suffered...
Campath Lawsuit
The FDA recently issued an urgent Drug Safety Alert indicating that alemtuzumab, the active ingredient in leukemia treatment Campath, had been linked to an increased risk for stroke and blood vessel wall tears (arterial dissection).
Lemtrada Class Action
Our class action lawyers are investigating potential lawsuits for people who suffered major injuries after taking the multiple sclerosis drug Lemtrada (generic: alemtuzumab), which has recently been linked to an increased risk for stroke, blood vessel wall tears (arterial dissection),...
Lemtrada Lawsuit
The U.S. Food & Drug Administration (FDA) on November 29, 2018, issued an urgent Drug Safety Communication indicating that the multiple sclerosis (MS) treatment Lemtrada (generic: alemtuzumab) will henceforth carry a boxed warning -- the strongest warning allowed by U.S....